News & Events

Cambridge, MA, June 9, 2005 -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will webcast its corporate presentation at Goldman Sachs' 26th Annual Global Healthcare Conference in Dana Point, California. A presentation and discussion will be conducted by Joshua Boger, Ph.D., Vertex's Chairman, President and Chief Executive Officer, on Tuesday, June 14, 2005 at 7:30 a.m. PDT.

The presentation will be webcast live and may be accessed by visiting the Vertex website at www.vrtx.com. A replay of the webcast will also be available on the Company's website until June 28, 2005. To access the audio webcast, go to Vertex's website and select 'Goldman Sachs' 26th Annual Global Healthcare Conference.' To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled webcast.

About Vertex

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes the HIV protease inhibitor, Lexiva®, with GlaxoSmithKline.

Lexiva® is a registered trademark of the GlaxoSmithKline group of companies.

Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755